期刊文献+
共找到64篇文章
< 1 2 4 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
3
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
4
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
INTRODUCTIONHepatolenticulardegeneration(HLD)isanautosomalrecesivedisorderthatcauseschangesinthebasalganglia... INTRODUCTIONHepatolenticulardegeneration(HLD)isanautosomalrecesivedisorderthatcauseschangesinthebasalgangliaandliverthatrespe... 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
5
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
6
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
7
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
8
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
9
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
氨磷汀联合紫杉醇、卡铂治疗卵巢癌的临床效果
10
作者 曹云 《妇儿健康导刊》 2023年第13期120-122,共3页
目的探讨氨磷汀联合紫杉醇、卡铂治疗卵巢癌的临床效果。方法选取2020年1月至2022年11月山西省肿瘤医院收治的156例卵巢癌患者,按照不同治疗方法分为对比组和联合组,每组各78例。对比组采用紫杉醇+卡铂化疗方案,联合组在对比组基础上联... 目的探讨氨磷汀联合紫杉醇、卡铂治疗卵巢癌的临床效果。方法选取2020年1月至2022年11月山西省肿瘤医院收治的156例卵巢癌患者,按照不同治疗方法分为对比组和联合组,每组各78例。对比组采用紫杉醇+卡铂化疗方案,联合组在对比组基础上联合氨磷汀。比较两组治疗效果、肿瘤标志物水平、不良反应发生情况。结果联合组治疗总有效率高于对比组(P<0.05)。治疗后,联合组肿瘤标志物水平均低于对比组(P<0.05)。联合组骨髓抑制、周围神经毒性反应发生率低于对比组(P<0.05)。结论氨磷汀联合紫杉醇、卡铂治疗卵巢癌可提高临床效果,有利于控制肿瘤进展并降低肿瘤标志物水平,有效避免骨髓抑制、周围神经毒性反应的发生。 展开更多
关键词 氨磷汀 紫杉醇 卡铂 卵巢癌 治疗效果
下载PDF
卡铂AUC剂量对中国人群上皮性卵巢癌患者疗效和安全性的影响 被引量:1
11
作者 景卫 汪蕾 +4 位作者 韩露 李敏 周雪 郭苗 李奇灵 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2023年第2期243-250,共8页
目的回顾分析西安交大一附院上皮性卵巢癌患者一线化疗中的实际平均卡铂剂量,按照Calvert公式反推出曲线下面积(area under the curve,AUC),比较AUC剂量的差异对中国人群的疗效和安全性影响。方法纳入2012年1月1日至2022年1月1日之间在... 目的回顾分析西安交大一附院上皮性卵巢癌患者一线化疗中的实际平均卡铂剂量,按照Calvert公式反推出曲线下面积(area under the curve,AUC),比较AUC剂量的差异对中国人群的疗效和安全性影响。方法纳入2012年1月1日至2022年1月1日之间在西安交大一附院首次接受紫杉醇+卡铂3周疗方案一线化疗的患者。根据AUC中位数,将患者分为高剂量和低剂量组,比较其客观缓解率(overall response rate,ORR)、疾病控制率(disease control rate,DCR)、无进展生存期(progression free survival,PFS)和总生存期(overall survival,OS),以及不良事件(adverse events,AEs)的发生率。结果共纳入153例患者,卡铂AUC的中位数为3.981(2.314~5.446)。AUC≥5的患者只有10.46%(16/153)。77例患者AUC<4,76例患者AUC≥4,两组患者基线特性无统计学差异(P>0.05)。两组的ORR分别为59.74%和57.89%,DCR分别为87.01%和85.53%;中位PFS分别为14、15.5个月,中位OS分别为50、55个月。上述结局指标在组间均无统计学差异(P>0.05)。血液学AEs中血红蛋白、中性粒细胞和血小板减少在组间有统计学差异;恶心呕吐、腹泻便秘、1-2级发热在组间有统计学差异(P<0.05)。此外,剂量限制性毒性(dose limiting toxicity,DLT)指标包括4级血小板减少和发热性中性粒细胞减少,在高剂量组发生率显著升高(P<0.05)。结论与国外指南推荐的卡铂AUC 5-6比较,我院卵巢癌一线化疗实际卡铂给药剂量普遍不足。低剂量组和高剂量组患者疗效没有统计学差异,但是鉴于高剂量组部分AEs发生风险增加、DLT风险增加,不建议盲目增加卡铂AUC剂量。 展开更多
关键词 卡铂 上皮性卵巢癌 AUC 一线化疗 疗效 不良事件 剂量限制性毒性
下载PDF
The role of drug utilization evaluation in medical sciences
12
作者 Ruby Gangwar Arvind Kumar +2 位作者 Abrar Ahmed Zargar Amit Sharma Ranjeet Kumar 《Global Health Journal》 2023年第1期3-8,共6页
Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in ... Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in society.The WHO recommends a physician to every 1000 people.According to the recent data from the Health Ministry in 2019,in which 1.16 million doctors are of active population with just 80%,or 0.9 million,practicing.As a result,a ratio of 0.68 doctors for every 1000 people,which is much below as per the WHO reports.This article describes history,types,WHO guidelines,need and purpose of DUE.Objective:The main aim of this paper is to provide information about the rational use of medication in outpa­tient and inpatient department with special emphasis of DUEs.It also provides awareness directly to healthcare professionals,researchers,academicians,pharmacist and nurses to reduce the irrationality of medicines.Methods:The method used to compile this review information gathered from websites,Google scholar,PubMed,Research gate,and studies published on DUE from July 20 to Oct 22 were included as source of information.Results:We studied more than 35 published study on DUE,that reveals most of the physicians prescribed branded drugs not generic drugs,but WHO prescribing indicator allows to prescribe generic drugs in the hospital pharmacy to maintain better inventory control.It may also help to prevent pharmacist misunderstanding during dispensing.Conclusion:The use of generic prescription names avoids the possibility of medication product duplication and lowers patient costs.It is important to remember that incorrect medication prescriptions have impact on both patients and their family members.WHO indicators identify irrational prescribing behaviours to make therapy more rational and cost-effective. 展开更多
关键词 Anatomical therapeutic chemical classification Drug utilization evaluation Prescribing indicators Pregnancy risk classification Rational use of the drug
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
13
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
环孢素影响化疗药物对视网膜母细胞瘤细胞的抑制作用 被引量:5
14
作者 毛羽翔 吴中耀 +2 位作者 杨华胜 郑健 林少芬 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2004年第3期212-216,共5页
【目的】 评价不同浓度环孢素(cyclosporin, CSA)影响化疗药物卡铂与足叶乙甙抑制视网膜母细胞瘤(retinoblastoma, Rb)细胞的促效作用?【方法】 实验分为卡铂组(G1)?卡铂+0.5 mg/L CSA组(G2)?卡铂+1.0 mg/L CSA组(G3)及足叶乙甙组(G4)?... 【目的】 评价不同浓度环孢素(cyclosporin, CSA)影响化疗药物卡铂与足叶乙甙抑制视网膜母细胞瘤(retinoblastoma, Rb)细胞的促效作用?【方法】 实验分为卡铂组(G1)?卡铂+0.5 mg/L CSA组(G2)?卡铂+1.0 mg/L CSA组(G3)及足叶乙甙组(G4)?足叶乙甙+0.5 mg/L CSA组(G5)?足叶乙甙+1.0 mg/L CSA组(G6),每组各加样5孔?G7组为不同浓度CSA单独作用于Rb细胞?用从0.004至1.00 mg/L倍数增加的9个不同浓度含量化疗药物卡铂和足叶乙甙及加入0.5 mg/L和1.0 mg/L浓度的环孢素作用于体外培养的SO-Rb50细胞?采用MTT法比较各组Rb细胞的生长抑制情况,通过计算Rb细胞抑瘤率?半数细胞抑制所需药物浓度IC50值及倒置显微镜下Rb细胞形态学检查,观察环孢素影响化疗药物抑制Rb细胞的作用?【结果】 卡铂及足叶乙甙加入CSA作用于SO-Rb50细胞,其细胞抑瘤率较单独应用卡铂及足叶乙甙时增高,G1~G6组的IC50值(mg/L)分别为:0.335 ?0.183 ?0.130?0.113?0.099?0.077 ,随着CSA的加用及浓度的增加,IC50值逐渐降低?G1与G2?G3组及G4与G5?G6组的抑瘤率分别作t检验,统计学分析均有显著性差异(P< 0.01)?G1与G2?G3组及G4与G5?G6组IC50的分别作方差分析检验,统计学分析均有显著性差异(P=0.005)?单纯CSA组抑瘤率与药物浓度无相关关系(P >0.1)? 展开更多
关键词 环孢素 化疗药物 视网膜母细胞瘤 肿瘤抑制 细胞形态学
下载PDF
卡铂Ⅲ期临床试用结果(附419例恶性肿瘤疗效分析) 被引量:14
15
作者 张弘纲 王奇璐 +2 位作者 王宏羽 王子平 谢雅莉 《实用肿瘤杂志》 CAS 北大核心 1996年第2期66-69,共4页
以卡铂或以卡铂为主的化疗方案治疗419例恶性肿瘤的前瞻性Ⅲ期临床试用的结果表明:以卡铂为主的联合化疗共360例,对小细胞肺癌的有效率为66.3%,对乳腺癌、食管癌及非小细胞肺癌的有效率分别为59.3%、55.6%和3... 以卡铂或以卡铂为主的化疗方案治疗419例恶性肿瘤的前瞻性Ⅲ期临床试用的结果表明:以卡铂为主的联合化疗共360例,对小细胞肺癌的有效率为66.3%,对乳腺癌、食管癌及非小细胞肺癌的有效率分别为59.3%、55.6%和34.1%。卡铂动脉插管化疗38例,对原发性肝癌及其他肿瘤的有效率分别为33.3%和52.9%,胸腹腔恶性积液21例的有效率为80.9%。另有291例无客观疗效指标和上述的419例共710例一起观察毒性。卡铂的主要毒性反应为骨髓抑制,少数病例有一过性肝功能损害。卡铂的胃肠反应轻,对肾功能影响很小,未观察到神经及耳毒性。 展开更多
关键词 肺肿瘤 药物疗法 卡铂 副作用 疗效
下载PDF
多西紫杉醇加铂类两周方案治疗晚期非小细胞肺癌的疗效和生活质量评价 被引量:6
16
作者 吴海鹰 戴文清 +3 位作者 刘俊玲 段海波 黄蕾 史艳侠 《中华肿瘤防治杂志》 CAS 2006年第17期1325-1328,共4页
目的:研究多西紫杉醇加铂类药物2周给药一线治疗晚期非小细胞肺癌(non-smallcelllungcancer,NSCLC)的疗效、毒副反应及生活质量评价。方法:多西紫杉醇75mg/m2静脉滴入,加用卡铂300mg/m2静脉滴入或顺铂25mg/(m2·d)×3d静脉滴入... 目的:研究多西紫杉醇加铂类药物2周给药一线治疗晚期非小细胞肺癌(non-smallcelllungcancer,NSCLC)的疗效、毒副反应及生活质量评价。方法:多西紫杉醇75mg/m2静脉滴入,加用卡铂300mg/m2静脉滴入或顺铂25mg/(m2·d)×3d静脉滴入联合化疗,每2周重复疗程。化疗期间用G-CSF预防性支持治疗。采用EORTCQLQ-C30和QLQ-LC13量表评价患者生活质量。化疗前、下个疗程的前1d及化疗结束后给予评价患者生活质量。结果:47例初治的晚期NSCLC接受化疗,42例患者可评价疗效,其中1例(2·4%)CR,16例(38·1%)PR,24例(57·1%)SD,1例(2·4%)PD。总有效率RR为40·5%。多西紫杉醇加顺铂组28例,RR35·7%,SD60·7%,PD3·6%;多西紫杉醇加卡铂组14例,RR50·0%,SD50·0%。两组有效率比较差异无统计学意义,P=0·374。毒副反应主要为骨髓抑制、恶心呕吐、脱发、肌肉关节痛及疲劳等。化疗后患者躯体功能较化疗前提高,咳嗽、气促、咯血及肩痛等症状明显缓解,整体生活质量并未因化疗而下降。客观疗效稳定的患者与有效患者生活质量改善相似。结论:多西紫杉醇加铂类药物每2周给药是治疗晚期NSCLC的有效可行的方案,毒性反应患者可耐受,大部分患者在化疗后可获得明显的症状和生活质量的改善。 展开更多
关键词 非小细胞肺/药物疗法 紫杉酚/治疗应用 顺铂/治疗应用 卡铂/治疗应用 药物疗法 联合 生活质量
下载PDF
贝伐单抗联合PC化疗方案治疗复发性卵巢癌的疗效研究 被引量:11
17
作者 陈甦 金松 郑小妹 《西南国防医药》 CAS 2016年第2期154-157,共4页
目的探索贝伐单抗(BEV)联合紫杉醇、卡铂(PC方案)治疗复发性卵巢癌的疗效和安全性。方法将78例一线化疗后在3~6个月内复发的卵巢癌患者随机分为3组,每组26例,3 w为1个治疗周期。PC组于每周期第1、8 d静脉滴注紫杉醇175 mg/m2,第1 d... 目的探索贝伐单抗(BEV)联合紫杉醇、卡铂(PC方案)治疗复发性卵巢癌的疗效和安全性。方法将78例一线化疗后在3~6个月内复发的卵巢癌患者随机分为3组,每组26例,3 w为1个治疗周期。PC组于每周期第1、8 d静脉滴注紫杉醇175 mg/m2,第1 d静脉滴注卡铂400 mg/m2;BEV组于每周期第1 d给予BEV 15 mg/kg;联合组在PC组化疗方案的基础上,于每周期第1 d化疗结束1 h后静脉滴注BEV 15 mg/kg。每例患者至少接受3个周期的治疗,比较3组在临床缓解率(RR)、疾病控制率(DCR)、无进展生存期(PFS)、总生存期(OS)和不良反应方面的差异。结果 PC组RR为34.62%,DCR为69.23%,中位PFS和OS分别为5.81、13.27个月;BEV组RR为38.46%,DCR为76.92%,中位PFS和OS分别为6.50、14.69个月;联合组RR为69.23%,DCR为96.15%,中位PFS和OS分别为8.08、16.65个月。联合组在RR、DCR、中位PFS和中位OS上均高于PC组和BEV组(P〈0.05),而PC组与BEV组之间则均无显著性差异(P〉0.05);3组间的毒副反应无显著性差异(P〉0.05)。结论 BEV联合PC方案治疗复发性卵巢癌,可较好地缓解患者病情,改善患者生存时间,且未明显增加毒副反应。 展开更多
关键词 贝伐单抗 紫杉醇 卡铂 复发性卵巢癌 疗效
下载PDF
术前介入性化疗结合手术治疗在宫颈癌治疗中的应用效果观察 被引量:3
18
作者 刘翠 徐旭军 +1 位作者 谢树英 黄伟健 《广西医学》 CAS 2003年第8期1382-1384,共3页
目的 :探讨术前应用顺铂 (DDP)或卡铂 (Carboplatin)、表阿霉素 (EPI)介入性化疗结合手术治疗宫颈癌的方法和临床疗效。方法 :17例 ( A期 3例、 B期 4例、 A期 5例、 B期 5例 )宫颈癌患者于术前实施经股动脉插管至子宫动脉 ,髂内动脉前... 目的 :探讨术前应用顺铂 (DDP)或卡铂 (Carboplatin)、表阿霉素 (EPI)介入性化疗结合手术治疗宫颈癌的方法和临床疗效。方法 :17例 ( A期 3例、 B期 4例、 A期 5例、 B期 5例 )宫颈癌患者于术前实施经股动脉插管至子宫动脉 ,髂内动脉前干 ,先后分别灌注 DDP(90 m g/m2 ,或 Carboplatin30 0 m g/m2 )、表阿霉素 (6 0 mg/m2 )和明胶海绵颗粒栓塞剂进行栓塞肿瘤供血动脉。对适合手术治疗者 ,于介入性化疗后 3~ 4周行广泛性全子宫切除盆腔淋巴结清扫术。结果 :介入性化疗满 3周后病人子宫颈癌灶缩小 2 1.0 %~ 10 0 % ,平均 88.2 %。其中有 14例病人顺利地接受了广泛性全子宫切除治疗盆腔淋巴结清扫术 ,3例( A期 2例及 B期 1例 )病人介入治疗满 3周后于术前检查发现宫颈病灶完全消失 ,手术切除标本送病理检查未找到癌细胞。3例病人 ( A期 1例 , B期 2例 )宫颈病灶缩小不明显 ,未能进行手术治疗。结论 :对于宫颈癌 A~ B期病人 ,应用本方法化疗可有效地缩小肿瘤体积 ,结合手术治疗后 14例患者达到 展开更多
关键词 宫颈癌 手术治疗 术前介入性化疗 顺铂 卡铂 表阿霉素
下载PDF
紫杉醇联合卡铂治疗Ⅲb期和Ⅳ期非小细胞肺癌的临床观察 被引量:3
19
作者 程玉龙 庄永志 《中国药房》 CAS CSCD 2003年第10期612-613,共2页
目的 :观察紫杉醇联合卡铂治疗晚期非小细胞肺癌的临床疗效及毒副反应。方法 :经病理学或细胞学证实的Ⅲb期和Ⅳ期非小细胞肺癌患者37例 ,第1天以紫杉醇 (150mg/m2)加入0 9 %生理盐水中静脉滴注4小时~6小时 ;第2天再以卡铂 (AUC6)静脉... 目的 :观察紫杉醇联合卡铂治疗晚期非小细胞肺癌的临床疗效及毒副反应。方法 :经病理学或细胞学证实的Ⅲb期和Ⅳ期非小细胞肺癌患者37例 ,第1天以紫杉醇 (150mg/m2)加入0 9 %生理盐水中静脉滴注4小时~6小时 ;第2天再以卡铂 (AUC6)静脉滴注 ,交替用药 ,21天为1周期 ,至少完成2个周期。结果 :37例患者中完全缓解3例 ,部分缓解15例 ,稳定13例 ,进展6例 ,总有效率 (完全缓解 +部分缓解 )为48 6 % ,1年生存率为51 3 % ;主要的毒副反应为肌肉酸痛及骨髓抑制 ,绝大多数患者耐受良好。结论 :紫杉醇联合卡铂治疗晚期非小细胞肺癌疗效确切 。 展开更多
关键词 紫杉醇 卡铂 联合 非小细胞肺癌 疗效观察
下载PDF
晚期非小细胞肺癌肿瘤组织和外周血淋巴细胞中RRM1和ERCC1基因表达的研究 被引量:2
20
作者 张国兵 陈建 +4 位作者 王临润 李菌 李敏伟 徐农 申屠建中 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2012年第5期540-546,共7页
目的:探讨晚期非小细胞肺癌(NSCLC)肿瘤组织和外周血淋巴细胞中RRM1、ERCC1基因表达水平及其临床意义。方法:应用实时荧光定量PCR技术检测49例晚期NSCLC肿瘤组织和外周血淋巴细胞中RRM1、ERCC1 mRNA表达水平,对照分析其与患者临床特征... 目的:探讨晚期非小细胞肺癌(NSCLC)肿瘤组织和外周血淋巴细胞中RRM1、ERCC1基因表达水平及其临床意义。方法:应用实时荧光定量PCR技术检测49例晚期NSCLC肿瘤组织和外周血淋巴细胞中RRM1、ERCC1 mRNA表达水平,对照分析其与患者临床特征、吉西他滨/卡铂方案的化疗反应以及预后的关系。结果:肿瘤组织和外周血淋巴细胞中RRM1表达水平呈正相关(rs=0.332,P<0.05),而ERCC1无相关(rs=0.258,P>0.05);肿瘤组织或外周血淋巴细胞中RRM1和ERCC1表达几乎同步(rs=0.634、0.351,P<0.05),但基因表达与患者的性别、年龄、吸烟状态、体力状况PS评分,以及肿瘤临床分期和组织学类型均无显著相关性(P均>0.05)。肿瘤组织中RRM1、ERCC1或外周血RRM1低表达者化疗有效率、中位生存期及1年生存率均高于高表达者,两者比较差异均有统计学意义(P<0.05),特别是肿瘤组织ERCC1低表达者有较高的2年生存率(P<0.05);而外周血ERCC1表达水平与化疗疗效以及预后均无相关性(P均>0.05)。结论:肿瘤组织中RRM1、ERCC1和外周血淋巴细胞中RRM1基因表达水平可能与晚期NSCLC患者吉西他滨/卡铂化疗的疗效以及预后密切相关。 展开更多
关键词 非小细胞肺/病理学 肺肿瘤/病理学 聚合酶链反应 核苷酸还原酶类/生物合成 DNA结合蛋白质类/生物合成 脱氧胞苷/治疗应用 脱氧胞苷/类似物和衍生物 卡铂/治疗应用 基因表达
下载PDF
上一页 1 2 4 下一页 到第
使用帮助 返回顶部